Related references
Note: Only part of the references are listed.Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh et al.
CANCER RESEARCH (2014)
T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
Feng Yu et al.
MOLECULAR THERAPY (2014)
BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice
Chengwen Liu et al.
CLINICAL CANCER RESEARCH (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
Rikke B. Holmgaard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
Christel Devaud et al.
ONCOIMMUNOLOGY (2013)
Effects of conventional therapeutic interventions on the number and function of regulatory T cells
Mario Roselli et al.
ONCOIMMUNOLOGY (2013)
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
A. Popple et al.
BRITISH JOURNAL OF CANCER (2012)
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy
Rebecca Waitz et al.
CANCER RESEARCH (2012)
T-Cell Trafficking Facilitated by High Endothelial Venules Is Required for Tumor Control after Regulatory T-Cell Depletion
James P. Hindley et al.
CANCER RESEARCH (2012)
PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines
Weiyi Peng et al.
CANCER RESEARCH (2012)
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew et al.
GUT (2012)
CTLA-4 Blockade Expands Infiltrating T Cells and Inhibits Cancer Cell Repopulation during the Intervals of Chemotherapy in Murine Mesothelioma
Licun Wu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine
Chantal G. Lemay et al.
MOLECULAR THERAPY (2012)
Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells
Vivian L. Weiss et al.
PLOS ONE (2012)
Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
James S. Wilmott et al.
ONCOIMMUNOLOGY (2012)
Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
Michelle Hong et al.
CANCER RESEARCH (2011)
Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer
Ludovic Martinet et al.
CANCER RESEARCH (2011)
CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
Rong Rong Huang et al.
CLINICAL CANCER RESEARCH (2011)
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Barbara Molon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions
Alessandra Nardin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
Anna M. Dahlin et al.
MODERN PATHOLOGY (2011)
Metronomic Cyclophosphamide andMethotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer
Jorge L. Soriano et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2011)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Efficient Treg depletion induces T-cell infiltration and rejection of large tumors
Xingrui Li et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Memory T-cell trafficking: new directions for busy commuters
Federica M. Marelli-Berg et al.
IMMUNOLOGY (2010)
Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response
Nan Soon Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Correlation of CXCL12 Expression and FoxP3+ Cell Infiltration with Human Papillomavirus Infection and Clinicopathological Progression of Cervical Cancer
Fatimah Jaafar et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions
Jennifer K. Mulligan et al.
HUMAN IMMUNOLOGY (2009)
Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer
N. Yoshitake et al.
BRITISH JOURNAL OF CANCER (2008)
The highway code of T cell trafficking
F. M. Marelli-Berg et al.
JOURNAL OF PATHOLOGY (2008)
Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors
Carl C. Schimanski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Organ selectivity in metastasis: regulation by chemokines and their receptors
Adit Ben-Baruch
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall
Ravi M. Rao et al.
CIRCULATION RESEARCH (2007)
High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer
Shozo Hojo et al.
CANCER RESEARCH (2007)
Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer
Charles Bailey et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Ilona Kryczek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Differential effects of immunosuppressive drugs on T-cell motility
A. Datta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
Anita E. M. Dirkx et al.
FASEB JOURNAL (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Fugetaxis: active movement of leukocytes away from a chemokinetic agent
F Vianello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Cognate recognition of the endothelium induces HY-specific CD8+ T-lymphocyte transendothelial migration (diapedesis) in vivo
FM Marelli-Berg et al.
BLOOD (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?
FM Marelli-Berg et al.
IMMUNOLOGY LETTERS (2004)
Migration and differentiation of CD8+ T cells
W Weninger et al.
IMMUNOLOGICAL REVIEWS (2002)
Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-A peptide multimer+ CD8+ T cells in humans
V Dutoit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway Hyperreactivity
NW Lukacs et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells:: A mechanism of immunoregulation?
FM Marelli-Berg et al.
JOURNAL OF IMMUNOLOGY (2000)
Active movement of T cells away from a chemokine
MC Poznansky et al.
NATURE MEDICINE (2000)